amlodipine and fimasartan

amlodipine has been researched along with fimasartan in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	7 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, JY; Jang, IJ; Kim, TE; Shin, SG; Yi, S; Yoon, SH; Yu, KS	1
Ahn, T; Ahn, Y; Bae Park, J; Cho, EJ; Choi, DJ; Chull Chae, S; Chun, KJ; Han, KR; Hyon, MS; Jeon, ES; Jeong, JO; Joo, SJ; Kim, DI; Kim, DS; Kim, JJ; Kim, KS; Kim, YJ; Kwan, J; Lee, HY; Oh, SK; Park, JS; Rhee, MY; Seog Seo, H; Shin, JH; Sung, KC; Yoo, BS; Youn, HJ	1
Cha, KS; Chae, SC; Chun, KJ; Ihm, SH; Il Kim, D; Jeong, JO; Joo, SJ; Kim, CH; Kim, DS; Kim, JJ; Kim, KH; Kim, KI; Kim, MH; Kim, YJ; Nam, CW; Park, S; Park, SM; Rhee, MY; Seo, HS; Shin, ES; Shin, J; Shin, MS; Sung, KC; Yoo, BS; Youn, HJ	1
Ahn, CH; Cho, YM; Jung, HS; Kim, S; Kwak, SH; Lee, SO; Lim, MH; Mari, A; Park, KS; Roh, E; Yang, YS	1
Ghim, JL; Kim, EY; Oh, M; Park, SE; Shin, JG	1
Jeon, I; Kim, E; Lee, HA; Lee, S; Rhee, SJ; Song, IS; Yu, KS	1
Ahn, JM; Kang, SJ; Kim, YH; Lee, CW; Lee, SW; Moon, DH; Oh, M; Park, DW; Park, SJ; Park, SW	1

Trials

5 trial(s) available for amlodipine and fimasartan

Article	Year
Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers. Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:6 Topics: Adult; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Renin; Tetrazoles; Young Adult	2011
A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension. Clinical therapeutics, 2015, Nov-01, Volume: 37, Issue:11 Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Essential Hypertension; Female; Headache; Humans; Hypertension; Male; Middle Aged; Pyrimidines; Tetrazoles	2015
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy. Clinical therapeutics, 2016, Volume: 38, Issue:10 Topics: Aged; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Essential Hypertension; Female; Humans; Hypertension; Male; Middle Aged; Pyrimidines; Tetrazoles	2016
Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects. Drug design, development and therapy, 2018, Volume: 12 Topics: Administration, Oral; Adult; Amlodipine; Biphenyl Compounds; Drug Combinations; Drug Design; Healthy Volunteers; Humans; Male; Middle Aged; Pyrimidines; Republic of Korea; Rosuvastatin Calcium; Tetrazoles; Young Adult	2018
Comparison of fimasartan and amlodipine therapy on carotid atherosclerotic plaque inflammation. Clinical cardiology, 2019, Volume: 42, Issue:2 Topics: Amlodipine; Biphenyl Compounds; Calcium Channel Blockers; Carotid Arteries; Carotid Artery Diseases; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Prospective Studies; Pyrimidines; Tetrazoles; Treatment Outcome	2019

Other Studies

2 other study(ies) available for amlodipine and fimasartan

Article	Year
Fimasartan increases glucose-stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine. Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:7 Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Pyrimidines; Tetrazoles	2018
Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction Potentials. Pharmaceutical research, 2018, Oct-15, Volume: 35, Issue:12 Topics: Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Computer Simulation; Drug Interactions; Humans; Hydrochlorothiazide; Models, Biological; Pyrimidines; Software; Tetrazoles	2018

Article

Year

Fimasartan increases glucose-stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine.

Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:7

Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Pyrimidines; Tetrazoles

2018

Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction Potentials.

Pharmaceutical research, 2018, Oct-15, Volume: 35, Issue:12

Topics: Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Computer Simulation; Drug Interactions; Humans; Hydrochlorothiazide; Models, Biological; Pyrimidines; Software; Tetrazoles

2018